Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06142097 · ClinicalTrials.gov registry record
Sensor Technology Assessments of Reproductive Target Study
A clinical trial, sponsored by Ouraring.
- Completed
- Registry status
- 119
- Enrollment target
NCT06142097 is a clinical trial that has completed, run by Ouraring. The registered enrollment target is 119 participants.
The verdict
NCT06142097 has completed, sponsored by Ouraring.
- COMPLETED
- Registry status
- 119 participants
- Enrollment target
Study Summary
The objective of this study was to better understand female reproductive health in the context of using wearable technology. Participants were provided and wore an Oura Ring, tracked their menstrual cycles, provided at-home ovulation test results, and had their cycles monitored via trans-vaginal ultrasounds. The study aimed to collect data from females with regular menstrual cycles.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 119 participants |
| Start Date | 2022-06-15 |
| Est. Completion | 2024-09-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06142097
The ClinicalTrials.gov registry entry for NCT06142097 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 119 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ouraring, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT06142097 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06142097 about?
NCT06142097 is a clinical study titled "Sensor Technology Assessments of Reproductive Target Study". The objective of this study was to better understand female reproductive health in the context of using wearable technology. Participants were provided and wore an Oura Ring, tracked their menstrual cycles, provided at-home ovulation test results, and had their cycles monitored via trans-vaginal ult...
What is the current status of trial NCT06142097?
This trial is currently completed. The enrollment target is 119 participants. The study started on 2022-06-15. Estimated completion is 2024-09-30.
Who is sponsoring clinical trial NCT06142097?
This trial is sponsored by Ouraring, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.